Suppr超能文献

COVID-19 疾病表现和严重程度的免疫决定因素。

Immune determinants of COVID-19 disease presentation and severity.

机构信息

Science for Life Laboratory, Department. of Women's and Children's Health, Karolinska Institutet, Solna, Sweden.

Pediatric Rheumatology, Karolinska University Hospital, Solna, Sweden.

出版信息

Nat Med. 2021 Jan;27(1):28-33. doi: 10.1038/s41591-020-01202-8. Epub 2021 Jan 13.

Abstract

COVID-19, caused by SARS-CoV-2 infection, is mild to moderate in the majority of previously healthy individuals, but can cause life-threatening disease or persistent debilitating symptoms in some cases. The most important determinant of disease severity is age, with individuals over 65 years having the greatest risk of requiring intensive care, and men are more susceptible than women. In contrast to other respiratory viral infections, young children seem to be less severely affected. It is now clear that mild to severe acute infection is not the only outcome of COVID-19, and long-lasting symptoms are also possible. In contrast to severe acute COVID-19, such 'long COVID' is seemingly more likely in women than in men. Also, postinfectious hyperinflammatory disease has been described as an additional outcome after SARS-CoV-2 infection. Here I discuss our current understanding of the immunological determinants of COVID-19 disease presentation and severity and relate this to known immune-system differences between young and old people and between men and women, and other factors associated with different disease presentations and severity.

摘要

新型冠状病毒(SARS-CoV-2)感染引起的 COVID-19,在大多数既往健康的个体中为轻症至中度,但在某些情况下可导致危及生命的疾病或持续性衰弱症状。疾病严重程度的最重要决定因素是年龄,65 岁以上人群需要重症监护的风险最大,男性比女性更容易患病。与其他呼吸道病毒感染不同,儿童似乎受影响较轻。现在很明显,轻症至重症急性感染并非 COVID-19 的唯一结局,也可能出现持久的症状。与严重急性 COVID-19 不同,这种“长新冠”在女性中似乎比男性更常见。此外,感染后超炎症性疾病也被描述为 SARS-CoV-2 感染后的另一种结局。在此,我讨论了我们目前对 COVID-19 疾病表现和严重程度的免疫学决定因素的理解,并将其与年轻人和老年人以及男性和女性之间已知的免疫系统差异以及与不同疾病表现和严重程度相关的其他因素联系起来。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验